Envelope-to: renata@bewonderful.com.br
Delivery-date: Mon, 14 Oct 2024 15:45:13 -0300
From: Rebeca Caires Contente Longatto <rebeca.longatto@hypera.com.br>
To: Renata de Cristofaro <renata@bewonderful.com.br>
CC: Maria Eduarda Silva Camargo <maria.e.camargo@hypera.com.br>
Subject: RES: RES: Proposta 10.670 > Re: Arte Feira Medicamental
Thread-Topic: RES: Proposta 10.670 > Re: Arte Feira Medicamental
Thread-Index: AQHbHlKk0x5IY82wVUaMbYktE5sv4LKGlUrg
Date: Mon, 14 Oct 2024 18:44:14 +0000
Message-ID:
 <RO2P152MB6093F8FCD4D7B09392E1D42DA4442@RO2P152MB6093.LAMP152.PROD.OUTLOOK.COM>
References: <hgQDfy13Wj8KfhjBFJxhnV5deTiuCvwmmczoOUI@www.mkt.tools>
In-Reply-To: <hgQDfy13Wj8KfhjBFJxhnV5deTiuCvwmmczoOUI@www.mkt.tools>
Accept-Language: pt-BR, en-US
Content-Language: pt-BR
x-ms-exchange-antispam-messagedata-chunkcount: 1
x-ms-exchange-antispam-messagedata-0:
 =?iso-8859-1?Q?RmsGfoBFkbs296MKI6CXUtw+QgbkwVE7uX6IdGuaEOnvCwT1qIRHWcPRrs?=
 =?iso-8859-1?Q?5ttd+tY7pJeKzTHu9yWjgD2trQSC1bmaLE1Q1OTmiDh1j7JAEL/BY9rfcR?=
 =?iso-8859-1?Q?izhYHAPdEGtF+g2i/V4u1JpzLaW4UxAGQrguc1mdGX3CvHDWD/MrDJZz+3?=
 =?iso-8859-1?Q?EwVUlPFCn45xVUkj/i7HJ9J1lDxCI6KSmRPJq4nPSWrkJxPENDSioTgZx5?=
 =?iso-8859-1?Q?Acj4bnqn9CneB57GvKgnZU7GBTJrYEgYe8a8reDFUltN1C7bDFWs2BF5dM?=
 =?iso-8859-1?Q?E0jm2jbspW+3e3/AxFfNBofi9kHwUW9QXwQagyeTMTaBMkRErBONzRkUac?=
 =?iso-8859-1?Q?QgChBBANyTBgWt8IyR2N+39p9OVRqiYNBLUOC7colKUVdr69lAargkn6oG?=
 =?iso-8859-1?Q?xi6WLIia6eTlQsJYfLpazsO4DYFhXBUuTgHlLOsPUnhi6PG9DDKQ+ox7kc?=
 =?iso-8859-1?Q?4YiYRcjfzKEHaXCg5H3rbDByCcahVQrVg4Jjopta/p/r2W1aXVSoSoIUWT?=
 =?iso-8859-1?Q?6sB9GGb33WYXpC6a/BD84GlYjNO7ybEzP3d8F8xBRZqsd/p00VlD/POgEl?=
 =?iso-8859-1?Q?g4xUyMAEJVfItbJXUVN4Ds9dE38VizQl2nSwiyNWs9keX/c+J2qEy8wwfC?=
 =?iso-8859-1?Q?3Gw1g7H6SqRgAN0L8CA+fpbRKzKRTtyVcZvdKIJAgREWMAmET0F6oF8XQa?=
 =?iso-8859-1?Q?l/xFV5/hxm0hMaDbD93O63zm8nhKs/IHfl7uMWtzTyJjWjHzTqpjgzSN3a?=
 =?iso-8859-1?Q?VSH3wybJ+s9tqpmtTeLoY+DXWacCfOs2xvaQG9pN52sS61VPR8n7YqjuBA?=
 =?iso-8859-1?Q?siqv7tI7cRVHYySuS8c86g4dd9oN9C+2plZOpsjmO2z0q5tfl0XK0JrCfY?=
 =?iso-8859-1?Q?y1taeFS4the8Ivb9wz68Ef8CZiFNBscINRlLS7S0jPHRjjCr4lfuSSQWJP?=
 =?iso-8859-1?Q?G1eyTdI9QMQD14TRh50qrcIxSdmpaDQ/qZB3v1nheiT6fREG7i+gnRNFyk?=
 =?iso-8859-1?Q?ccwMSXl8mEeU1AXFew86F8w17SNTLfHlOJVy28HwWZfAKYXxRWlTS7hc5c?=
 =?iso-8859-1?Q?ydLhlaILm5WJtN8HTNa4e0ItvtCZFtnUH8gGOTgoSU9OoAewYdOaiCnRWH?=
 =?iso-8859-1?Q?O+7JemFvlck5Fs4iF9WdPKtwLo5kXX8aWqbvVrnfKoXlrRPNwMXhBVHeZd?=
 =?iso-8859-1?Q?HtT5HtZCbR6zGZKf6Fv7MvsImXchHJ+SDz6uhStNCipk2PmHyPp6TKDOtY?=
 =?iso-8859-1?Q?hlmGdAzxW9j1wWWC/gkIkhd+lhZUxGjLNVCOeLKDqU+ggM3fUVB+Es1SjB?=
 =?iso-8859-1?Q?d8KrtGs2lS+zfqu663uGYhz7EAwwwQDwvMsMAgrSFJVc+7un85l5umBAY/?=
 =?iso-8859-1?Q?Hmu7Dgsy5ReRaDMk0y5WxzVAEYgnPvNj8QtCVZUouQi0G/ySfDM7kY/SCz?=
 =?iso-8859-1?Q?0yE0+Fk2OiFcWvf8EbXgoOYJEekPi06fpYJOJLwJgcbPFv2g0OT6sJw2rk?=
 =?iso-8859-1?Q?SoXKALy1azBr18zbVD6k6raXWwCCeEnUuGGRcRA1KmaVuB0P02Yirp4zYX?=
 =?iso-8859-1?Q?uAhyPYcCV5pMW2UXe6K+yFN9eWSwTLH1v5T+CFDHtjYRbVt4bi3O1RLc4p?=
 =?iso-8859-1?Q?Mmc2t7tlqrLl9HG6sf2nJ2y/tqYA6T1Obg4DXj41rMTxqR21IczkLakw?=
 =?iso-8859-1?Q?=3D=3D?=
Content-Type: multipart/related;
	boundary=\"_005_RO2P152MB6093F8FCD4D7B09392E1D42DA4442RO2P152MB6093LAMP_\";
	type=\"multipart/alternative\"
MIME-Version: 1.0
X-OriginatorOrg: hypera.com.br
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-AuthSource: RO2P152MB6093.LAMP152.PROD.OUTLOOK.COM
X-MS-Exchange-CrossTenant-Network-Message-Id: 17682444-2461-45e0-5038-08dcec80336c
X-MS-Exchange-CrossTenant-originalarrivaltime: 14 Oct 2024 18:44:14.2062
 (UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: 3f7a3df4-f85b-4ca8-98d0-08b1034e6567
X-MS-Exchange-CrossTenant-mailboxtype: HOSTED
X-MS-Exchange-CrossTenant-userprincipalname: EBNQXx+xp7oU1+1TJIH4dGBLkIhDWLf3VNsjXqQ3lqe7bRApTo7wZxfdLnYZuiEF72WwcnxH8uXM4GIXOokY2Omi7HzUyliMJTPzrqdOX/U=
X-MS-Exchange-Transport-CrossTenantHeadersStamped: CPVP152MB4590
X-Spam-Status: No, score=0.2
X-Spam-Score: 2
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system \"cloud.mkt.tools\",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\\@localhost for details.
 Content preview:  Oi Re, Como falamos, acabo de te enviar os mockups que temos
    disponíveis (imagino que vocę já os tem por aí). Qualquer dúvida avisa. Obrigada,
    abraços! Rebeca Longatto Hypera Pharma - Similares e Genéricos Trade Marketing
    Categoria rebeca.longatto@hypera.com.br<mailto:rebeca.longatto@hypera.com.br>
    [Capturar] 
 Content analysis details:   (0.2 points, 10.0 required)
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
 -0.0 SPF_PASS               SPF: sender matches SPF record
 -0.0 SPF_HELO_PASS          SPF: HELO matches SPF record
  0.0 HTML_MESSAGE           BODY: HTML included in message
  0.1 DKIM_SIGNED            Message has a DKIM or DK signature, not necessarily
                             valid
  0.0 KAM_DMARC_STATUS       Test Rule for DKIM or SPF Failure with Strict
                             Alignment
  0.1 DKIM_INVALID           DKIM or DK signature exists, but is not valid
X-Spam-Flag: NO